Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Gepubliceerd in:
1 Psychiatrie ontward hoofdstuk lezen eerste hoofdstuk lezen

2018 | OriginalPaper | Hoofdstuk

8 Syndromen

Auteurs : Albert Leentjens, Frans Verhey

Gepubliceerd in: Innovatief leerboek persoonlijke psychiatrie

Uitgeverij: Bohn Stafleu van Loghum

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Samenvatting

In dit hoofdstuk gaan we naar de psychiatrisch beelden en de beschrijving van de verschillende syndromen.
vorige hoofdstuk 7 Onderzoek en diagnostiek
volgende hoofdstuk 9 Psychiatrie en bepaalde zorgonderdelen
Voetnoten
1
Dr. A.F.G.Leentjens is psychiater en universitair hoofddocent bij de Universiteit Maastricht.
Prof.dr. F.R.J. Verhey is zenuwarts, werkzaam als hoogleraar Ouderen- en neuropsychiatrie bij de Universiteit Maastricht.
 
2
Dr. Gabriël Esquivel is psychiater in opleiding.
Prof. dr. Koen Schruers is psychiater en werkzaam bij de vakgroep psychiatrie en neuropsychologie van de Universiteit Maastricht.
 
3
* Voor de personalia van prof.dr. E. Vermetten zie hoofdstuk 5.​1.​2. Voor de personalia van dr. Bart Rutten zie hoofdstuk 4.​1.​4.
 
4
Dr. Judith Rickelt is psychiater, werkzaam bij ggzE.
Voor de personalia van prof. dr. Koen Schruers zie hoofdstuk 8.2.
 
5
* Prof.dr. Jan Spijker is psychiater, werkzaam als bijzonder hoogleraar Chronische Depressie aan de Radbouduniversiteit.
 
6
* Prof.dr. Christina van der Feltz-Cornelis is psychiater, werkzaam als bijzonder hoogleraar Sociale Psychiatrie bij de Universiteit Tilburg.
 
7
* Prof.dr. Ralph Kupka is psychiater bij GGzinGeest en Altrecht en als hoogleraar bipolaire stoornissen werkzaam bij het vumc.
 
8
Dr. Wim Veling is psychiater, werkzaam als hoofd Behandelzaken bij de afdeling Psychosen, Universitair Centrum Psychiatrie van het umc Groningen.
Prof.dr. Lieuwe de Haan is psychiater, werkzaam als hoogleraar Psychotische Stoornissen bij de Universiteit van Amsterdam.
Voor de personalia van prof.dr. Jim van Os zie hoofdstuk 1.
 
9
* Prof.dr.Onno van der Hart is klinisch psycholoog, emeritus hoogleraar psychopathologie bij de Universiteit Utrecht.
Dr. Suzette Boon is klinisch psycholoog en werkzaam als psychotherapeut in haar eigen praktijk.
 
10
* Prof.dr. Loes Gabriëls is psychiater, was eerder hoogleraar aan de Katholieke universiteit Leuven en werkt momenteel bij het upc van de ku Leuven (Campus Gasthuisberg) en in haar eigen praktijk.
 
11
* Prof.dr. Annemarie van Elburg is (kinder)psychiater, werkzaam als hoogleraar Eetstoornissen bij de Universiteit Utrecht.
Prof.dr. Roger Adan is medisch bioloog, werkzaam als hoogleraar Moleculaire Farmacologie bij de Universiteit Utrecht.
 
12
* Drs. Matthijs Eendebak, msc, is psychiater in opleiding bij Lentis in Groningen.
Marion Mulder-Paalman is verpleegkundig specialist bij Lentis in Groningen Drs. Jona Gardien, is arts in opleiding bij umc Groningen.
Voor de personalia van dr. Rikus Knegtering zie hoofdstuk 6.​1.
Met dank aan Marrit de Boer, psychiater Universitair Centrum Psychiatrie in Groningen en Thalia Herder, psychiater in opleiding bij Lentis, voor het beschikbaar stellen van bronteksten en de figuur.
 
13
* Prof.dr. Geert Dom, psychiater, werkzaam als hoogleraar Verslavingspsychiatrie bij de Universiteit Antwerpen.
 
14
* Dr. Chris Bervoets, psychiater, werkzaam bij het universitair psychiatrisch centrum van de Katholieke Universiteit Leuven.
 
15
* Dr. Bram Sizoo is jurist en psychiater, werkzaam als hoofd Specialistisch Centrum Ontwikkelingsstoornissen bij Dimence
 
16
* Dr. Ad Kaasenbrood is psychiater, lid van fact-team Centraal Pro Persona in Arnhem, directeur Kenniscentrum Persoonlijkheidsstoornissen Utrecht.
Dr. Joost Hutsebaut is klinisch psycholoog, werkzaam als specialist in persoonlijkheid, gedrag en gezin bij De Viersprong en als medewerker Kenniscentrum Persoonlijkheidsstoornissen Utrecht.
 
Literatuur
1.
Fong EH, Catagnus RM, Brodhead MT, Quigley S, Field S. Developing the Cultural Awareness Skills of Behavior Analysts. Behavior Analysis in Practice. 2016;9(1):84-94. doi: 10.1007/s40617-016-0111-6.CrossRefPubMedPubMedCentral
2.
Querfurth HW, LaFerla FM. Alzheimer’s disease. N Engl J Med. 2010;362(4):329-44. doi: 10.1056/NEJMra0909142. PubMed pmid: 20107219.CrossRefPubMed
3.
Neuropathology Group of the medical Research Council Cognitive Function and Ageing Study Group (mrc cfas). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (mrc cfas). Lancet. 2001;357(9251):169-75. PubMed pmid: 11213093.
4.
Neuropathology Group. Medical Research Council Cognitive F, Aging S. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (mrc cfas). Lancet. 2001;357(9251):169-75. PubMed pmid: 11213093.
5.
Lashley T, Rohrer JD, Mead S, Revesz T. Review: an update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations. Neuropathol Appl Neurobiol. 2015;41(7):858-81. doi: 10.1111/nan.12250. PubMed pmid: 26041104.CrossRefPubMed
6.
Wu YT, Fratiglioni L, Matthews FE, Lobo A, Breteler MM, Skoog I, et al. Dementia in western Europe: epidemiological evidence and implications for policy making. Lancet Neurol. 2016;15(1):116-24. doi: 10.1016/S1474-4422(15)00092-7. PubMed pmid: 26300044.CrossRefPubMed
7.
Olde Rikkert MG, van Exel E, Knol W, Lemstra AW, Roks G, Verhey FR.Diagnostic guideline and treatment of dementia. Ned Tijdschr Geneeskd. 2015;159:A8671. PubMed pmid: 25873222.
8.
Ballard C, Corbett A. Agitation and aggression in people with Alzheimer’s disease. Curr Opin Psychiatry. 2013;26(3):252-9. doi: 10.1097/yco.0b013e32835f414b. PubMed pmid: 23528917.CrossRefPubMed
9.
de Vugt ME, Verhey FR. The impact of early dementia diagnosis and intervention on informal caregivers. Prog Neurobiol. 2013;110:54-62. doi: 10.1016/j.pneurobio.2013.04.005. PubMed pmid: 23689068.CrossRefPubMed
10.
Delier. Richtlijn delier: volwassenen en ouderen. Nederlandse Vereniging voor Klinische Geriatrie. Utrecht: 2014.
11.
National Clinical Guideline Centre. Delirium: diagnosis, prevention and management (clinical guideline 103). London: National Clinical Guideline Centre, 2010.
12.
American Psychiatric Association A. dsm-5: Diagnostic and Statistical Manual of Mental Disorders. Washinton DC.: apa. 2013.
13.
Leentjens AF, Eikelenboom P, van der Mast RC. Delier. In: van de Mast RC, Heeren T, Kat M, Stek M, Vandenbulcke M, Verheij F, redactie. Handboek Ouderenpsychiatrie. Utrecht: De Tijdstroom; 2010.
14.
Innouye SK. Predisposing and precipitating factors for delirium in hospitalized older patients. Dementie and Geriatric Cognitive Disorders. 1999;10:393-400.CrossRefPubMed
1.
Blanchard DC, Hynd AL, Minke KA, Minemoto T, Blanchard RJ. Human defensive behaviors to threat scenarios show parallels to fear- and anxiety-related defense patterns of nonhuman mammals. Neurosci Biobehav Rev. 2001;25(7-8):761-70. PubMed pmid: 11801300.
2.
McNaughton N, Corr PJ. A two-dimensional neuropsychology of defense: fear/anxiety and defensive distance. Neurosci Biobehav Rev. 2004;28(3):285-305. doi: 10.1016/j.neubiorev.2004.03.005. PubMed pmid: 15225972.CrossRef
3.
Leibold NK, van den Hove DL, Esquivel G, De Cort K, Goossens L, Strackx E, et al. The brain acid-base homeostasis and serotonin: A perspective on the use of carbon dioxide as human and rodent experimental model of panic. Prog Neurobiol. 2015;129:58-78. doi: 10.1016/j.pneurobio.2015.04.001. PubMed pmid: 25930682.CrossRefPubMed
4.
de Graaf R, ten Have M, van Gool C, van Dorsselaer S. Prevalence of mental disorders and trends from 1996 to 2009. Results from the Netherlands Mental Health Survey and Incidence Study-2. Soc Psychiatry Psychiatr Epidemiol. 2012;47(2):203-13. doi: 10.1007/s00127-010-0334-8. PubMed pmid: 21197531.CrossRefPubMed
5.
Walker DL, Toufexis DJ, Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol. 2003;463(1-3):199-216. PubMed pmid: 12600711.CrossRefPubMed
6.
Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry. 2001;158(10):1568-78. doi: 10.1176/appi.ajp.158.10.1568. PubMed pmid: 11578982CrossRefPubMed
7.
Klein DF. Historical aspects of anxiety. Dialogues Clin Neurosci. 2002;4(3):295-304. PubMed pmid: 22033777; PubMed Central pmcid: PMCPMC3181682.
8.
Mineka S, Zinbarg R. A contemporary learning theory perspective on the etiology of anxiety disorders: it’s not what you thought it was. Am Psychol. 2006;61(1):10-26. doi: 10.1037/0003-066X.61.1.10. PubMed pmid: 16435973.CrossRefPubMed
9.
Eley TC, McAdams TA, Rijsdijk FV, Lichtenstein P, Narusyte J, Reiss D, et al. The Intergenerational Transmission of Anxiety: A Children-of-Twins Study. Am J Psychiatry. 2015;172(7):630-7. doi: 10.1176/appi.ajp.2015.14070818. PubMed pmid: 25906669.CrossRefPubMed
1.
Yehuda R, Hoge CW, McFarlane AC, Vermetten E, Lanius RA, Nievergelt CM, et al. Posttraumatic stress disorder. Nat Rev Dis Primers. 2015;1:15057. doi: 10.1038/nrdp.2015.57. PubMed pmid: 27189040.
2.
Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, et al. The development of a Clinician-Administered ptsd Scale. J Trauma Stress. 1995;8(1):75-90. PubMed pmid: 7712061.CrossRefPubMed
3.
Dedert EA, Calhoun PS, Watkins LL, Sherwood A, Beckham JC. Posttraumatic stress disorder, cardiovascular, and metabolic disease: a review of the evidence. Ann Behav Med. 2010;39(1):61-78. doi: 10.1007/s12160-010-9165-9. PubMed pmid: 20174903; PubMed Central pmcid: PMCPMC3219414.CrossRefPubMed
4.
Marmar CR, McCaslin SE, Metzler TJ, Best S, Weiss DS, Fagan J, et al. Predictors of posttraumatic stress in police and other first responders. Ann N Y Acad Sci. 2006;1071:118. doi: 10.1196/annals.1364.001. PubMed pmid: 16891557.CrossRefPubMed
5.
Jongedijk RA, Carlier IV, Schreuder BJ, Gersons BP. Complex posttraumatic stress disorder: an exploratory investigation of ptsd and des nos among Dutch war veterans. J Trauma Stress. 1996;9(3):577-86. PubMed pmid: 8827657.PubMed
6.
Spiegel D, Lewis-Fernandez R, Lanius R, Vermetten E, Simeon D, Friedman M. Dissociative disorders in DSM-5. Annu Rev Clin Psychol. 2013;9:299-326. doi: 10.1146/annurevclmpsy-050212-185531. PubMed pmid: 23394228.
7.
Kessler RC. Posttraumatic stress disorder: the burden to the individual and to society. J Clin Psychiatry. 2000;61 Suppl 5:4-12; discussion 3-4. PubMed pmid: 10761674.
8.
Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52(12):1048-60. PubMed pmid: 7492257.CrossRefPubMed
9.
Wichers MC, Barge-Schaapveld DQ, Nicolson NA, Peeters F, de Vries M, Mengelers R, et al. Reduced stress-sensitivity or increased reward experience: the psychological mechanism of response to antidepressant medication. Neuropsychopharmacology. 2009;34(4):923-31. doi: 10.1038/npp.2008.66. PubMed pmid: 18496519.CrossRefPubMed
10.
Vermetten E, Baker DG, Jetly R, McFarlane AC. Concerns Over Divergent Approaches in the Diagnostics of Posttraumatic Stress Disorder. Psychiatric Annals. 2016;46(9):498-509.CrossRef
11.
Zannas AS, Provencal N, Binder EB. Epigenetics of Posttraumatic Stress Disorder: Current Evidence, Challenges, and Future Directions. Biol Psychiatry. 2015;78(5):327-35. doi: 10.1016/j.biopsych.2015.04.003. PubMed pmid: 25979620.CrossRefPubMed
12.
Michopoulos V, Norrholm SD, Jovanovic T. Diagnostic Biomarkers for Posttraumatic Stress Disorder: Promising Horizons from Translational Neuroscience Research. Biol Psychiatry. 2015;78(5):344-53. doi: 10.1016/j.biopsych.2015.01.005. PubMed pmid: 25727177; PubMed Central pmcid: PMCPMC4520791.CrossRefPubMedPubMedCentral
13.
McEwen BS. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology. 2000;22(2):108-24. doi: 10.1016/S0893-133X(99)00129-3. PubMed pmid: 10649824.CrossRefPubMed
14.
Hoskins M, Pearce J, Bethell A, Dankova L, Barbui C, Tol WA, et al. Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis. Br J Psychiatry. 2015;206(2):93-100. doi: 10.1192/bjp.bp.114.148551. PubMed pmid: 25644881.CrossRef
15.
Vermetten E, Zhohar J, Krugers HJ. Pharmacotherapy in the aftermath of trauma; opportunities in the ‘golden hours’. Curr Psychiatry Rep. 2014;16(7):455. doi: 10.1007/s11920-014-0455-y. PubMed pmid: 24890991.
16.
Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Martin SF, Yazar-Klosinski B, et al. Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamineassisted psychotherapy: a prospective long-term follow-up study. J Psychopharmacol. 2013;27(1):28-39. doi: 10.1177/0269881112456611. PubMed pmid: 23172889; PubMed Central PMCID: PMCPMC3573678.CrossRefPubMed
17.
Multidisciplinaire richtlijn Angststoornissen (3e revisie) (1.0). Utrecht: Trimbos; 2013.
18.
Schnyder U, Ehlers A, Elbert T, Foa EB, Gersons BP, Resick PA, et al. Psychotherapies for ptsd: what do they have in common? Eur J Psychotraumatol. 2015;6:28186. doi: 10.3402/ejpt.v6.28186. PubMed pmid: 26290178; PubMed Central pmcid: PMCPMC4541077.CrossRefPubMed
19.
Gupta MA. Review of somatic symptoms in post-traumatic stress disorder. Int Rev Psychiatry. 2013;25(1):86-99. doi: 10.3109/09540261.2012.736367. PubMed pmid: 23383670.CrossRefPubMed
1.
Mataix-Cols D, Rosario-Campos MC, Leckman JF. A multidimensional model of obsessivecompulsive disorder. Am J Psychiatry. 2005;162(2):228-38. doi: 10.1176/appi.ajp.162.2.228. PubMed pmid: 15677583.CrossRefPubMed
2.
Hofmeijer-Sevink MK, van Oppen P, van Megen HJ, Batelaan NM, Cath DC, van der Wee NJ, et al. Clinical relevance of comorbidity in obsessive compulsive disorder: the Netherlands ocd Association study. J Affect Disord. 2013;150(3):847-54. doi: 10.1016/j. jad.2013.03.014. PubMed pmid: 23597943.
3.
Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15(1):53- 63. doi: 10.1038/mp.2008.94. PubMed pmid: 18725912; PubMed Central pmcid: PMCPMC2797569.CrossRefPubMedPubMedCentral
4.
De Graaf R, Bijl RV, Ravelli A, Smit F, Vollebergh WA. Predictors of first incidence of dsm-iii-r psychiatric disorders in the general population: findings from the Netherlands Mental Health Survey and Incidence Study. Acta Psychiatr Scand. 2002;106(4):303-13. PubMed pmid: 12225498.CrossRefPubMed
5.
Angst J, Gamma A, Endrass J, Goodwin R, Ajdacic V, Eich D, et al. Obsessive-compulsive severity spectrum in the community: prevalence, comorbidity, and course. Eur Arch Psychiatry Clin Neurosci. 2004;254(3):156-64. doi: 10.1007/s00406-004-0459-4. PubMed PMID: 15205969.
6.
Voltas N, Hernandez-Martinez C, Arija V, Aparicio E, Canals J. A prospective study of paediatric obsessive-compulsive symptomatology in a Spanish community sample. Child Psychiatry Hum Dev. 2014;45(4):377-87. doi: 10.1007/s10578-013-0408-4. PubMed pmid: 24077908.CrossRef
7.
Boileau B. A review of obsessive-compulsive disorder in children and adolescents. Dialogues Clin Neurosci. 2011;13(4):401-11. PubMed pmid: 22275846; PubMed Central PMCID: PMCPMC3263388.
8.
Anholt GE, Aderka IM, van Balkom AJ, Smit JH, Schruers K, van der Wee NJ, et al. Age of onset in obsessive-compulsive disorder: admixture analysis with a large sample. Psychol Med. 2014;44(1):185-94. doi: 10.1017/s0033291713000470. PubMed pmid: 23517651.CrossRefPubMed
9.
Iervolino AC, Rijsdijk FV, Cherkas L, Fullana MA, Mataix-Cols D. A multivariate twin study of obsessive-compulsive symptom dimensions. Arch Gen Psychiatry. 2011;68(6):637-44. doi: 10.1001/archgenpsychiatry.2011.54. PubMed pmid: 21646580.CrossRefPubMed
10.
Pauls DL, Abramovitch A, Rauch SL, Geller DA. Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective. Nat Rev Neurosci. 2014;15(6):410-24. doi: 10.1038/nrn3746. PubMed pmid: 24840803.CrossRefPubMed
11.
van den Heuvel OA, Remijnse PL, Mataix-Cols D, Vrenken H, Groenewegen HJ, Uylings HB, et al. The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems. Brain. 2009;132(Pt 4):853-68. doi: 10.1093/brain/awn267. PubMed pmid: 18952675.CrossRefPubMed
12.
Milad MR, Rauch SL. Obsessive-compulsive disorder: beyond segregated corticostriatal pathways. Trends Cogn Sci. 2012;16(1):43-51. doi: 10.1016/j.tics.2011.11.003. PubMed pmid: 22138231.CrossRefPubMed
13.
van den Heuvel OA, van Wingen G, Soriano-Mas C, Alonso P, Chamberlain SR, Nakamae T, et al. Brain circuitry of compulsivity. Eur Neuropsychopharmacol. 2015. doi: 10.1016/j.euroneuro.2015.12.005. PubMed pmid: 26711687.CrossRefPubMed
14.
Brander G, Perez-Vigil A, Larsson H, Mataix-Cols D. Systematic review of environmental risk factors for Obsessive-Compulsive Disorder: A proposed roadmap from association to causation. Neurosci Biobehav Rev. 2016;65:36-62. doi: 10.1016/j.neubiorev.2016.03.011. PubMed pmid: 27013116.CrossRef
15.
Fineberg NA, Reghunandanan S, Simpson HB, Phillips KA, Richter MA, Matthews K, et al. Obsessive-compulsive disorder (ocd): Practical strategies for pharmacological and somatic treatment in adults. Psychiatry Res. 2015;227(1):114-25. doi: 10.1016/j.psychres.2014.12.003. PubMed pmid: 25681005.CrossRefPubMed
16.
Veale D, Miles S, Smallcombe N, Ghezai H, Goldacre B, Hodsoll J. Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis. bmc Psychiatry. 2014;14:317. doi: 10.1186/s12888-014-0317-5. PubMed pmid: 25432131; PubMed Central pmcid: PMCPMC4262998.
17.
Xia J, Du Y, Han J, Liu G, Wang X. D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis. Drug Des Devel Ther. 2015;9:2101-17. doi: 10.2147/dddt.s68994. PubMed pmid: 25960632; PubMed Central pmcid: PMCPMC4410826.
18.
Alonso P, Cuadras D, Gabriels L, Denys D, Goodman W, Greenberg BD, et al. Deep Brain Stimulation for Obsessive-Compulsive Disorder: A Meta-Analysis of Treatment Outcome and Predictors of Response. PLoS One. 2015;10(7):e0133591. doi: 10.1371/journal.pone.0133591. PubMed pmid: 26208305; PubMed Central pmcid: PMCPMC4514753.CrossRefPubMedPubMedCentral
19.
Multidisciplinaire richtlijn Angststoornissen (3e revisie) (1.0). Utrecht: Trimbos; 2013.
20.
McGuire JF, Piacentini J, Lewin AB, Brennan EA, Murphy TK, Storch EA. A Meta-Analysis of Cognitive Behavior Therapy and Medication for Child Obsessive-Compulsive Disorder: Moderators of Treatment Efficacy, Response, and Remission. Depress Anxiety. 2015;32(8):580-93. doi: 10.1002/da.22389. PubMed pmid: 26130211; PubMed Central pmcid: PMCPMC4515191.CrossRefPubMedPubMedCentral
21.
Ost LG, Havnen A, Hansen B, Kvale G. Cognitive behavioral treatments of obsessive-compulsive disorder. A systematic review and meta-analysis of studies published 1993-2014. Clin Psychol Rev. 2015;40:156-69. doi: 10.1016/j.cpr.2015.06.003. PubMed pmid: 26117062.CrossRefPubMed
22.
Skoog G, Skoog I. A 40-year follow-up of patients with obsessive-compulsive disordersee commetns. Arch Gen Psychiatry. 1999;56(2):121-7. PubMed pmid: 10025435.CrossRefPubMed
1.
Spijker J, Bockting CJH, Meeuwissen JAC. Multidisciplinaire richtlijn Depressie (Derde revisie): Richtlijn voor de diagnostiek, behandeling en begeleiding van volwassen patiënten met een depressieve stoornis. Utrecht: Trimbos Instituut; 2013.
2.
Bruffaerts R, Bonnewyn A, Demyttenaere K. Het voorkomen van depressie in België. Stand van zaken en reflecties voor de toekomst. Tijdschrift voor Psychiatrie. 2008;50(10):655-65.
3.
Bijl RV, Ravelli A, van Zessen G. Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (nemesis). Soc Psychiatry Psychiatr Epidemiol. 1998;33(12):587-95. PubMed pmid: 9857791.CrossRefPubMed
4.
de Graaf R, ten Have M, van Gool C, van Dorsselaer S. Prevalence of mental disorders and trends from 1996 to 2009. Results from the Netherlands Mental Health Survey and Incidence Study-2. Soc Psychiatry Psychiatr Epidemiol. 2012;47(2):203-13. doi: 10.1007/s00127-010-0334-8. PubMed pmid: 21197531.CrossRefPubMed
5.
Bijl RV, De Graaf R, Ravelli A, Smit F, Vollebergh WA, Netherlands Mental Health S, et al. Gender and age-specific first incidence of dsm-iii-r psychiatric disorders in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (nemesis). Soc Psychiatry Psychiatr Epidemiol. 2002;37(8):372-9. doi: 10.1007/s00127-002-0566-3. PubMed pmid: 12195544.CrossRefPubMed
6.
American Psychiatric Association A. dsm-5: Diagnostic and Statistical Manual of Mental Disorders. Washinton DC.: APA.; 2013.
7.
Penninx BW, Milaneschi Y, Lamers F, Vogelzangs N. Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. bmc Med. 2013;11:129. doi: 10.1186/1741-7015-11-129. PubMed pmid: 23672628; PubMed Central pmcid: pmcpmc3661358.
8.
Ormel J, Jeronimus BF, Kotov R, Riese H, Bos EH, Hankin B, et al. Neuroticism and common mental disorders: meaning and utility of a complex relationship. Clin Psychol Rev. 2013;33(5):686-97. doi: 10.1016/j.cpr.2013.04.003. PubMed pmid: 23702592; PubMed Central pmcid: pmcpmc4382368.CrossRefPubMedPubMedCentral
9.
Ormel J, Oldehinkel AJ, Brilman EI. The interplay and etiological continuity of neuroticism, difficulties, and life events in the etiology of major and subsyndromal, first and recurrent depressive episodes in later life. Am J Psychiatry. 2001;158(6):885-91. doi: 10.1176/appi.ajp.158.6.885. PubMed pmid: 11384895.CrossRefPubMed
1.
Escobar JI, Cook B, Chen CN, Gara MA, Alegria M, Interian A, et al. Whether medically unexplained or not, three or more concurrent somatic symptoms predict psychopathology and service use in community populations. J Psychosom Res. 2010;69(1):1-8.doi: 10.1016/j.jpsychores.2010.01.001. PubMed pmid: 20630257; PubMed Central pmcid: PMCPMC2905311.CrossRefPubMedPubMedCentral
2.
van der Feltz-Cornelis CM. Het Stressbeeld. Amsterdam: Uitgeverij Nieuwerzijds; 2014.
3.
Nimnuan C, Hotopf M, Wessely S. Medically unexplained symptoms: an epidemiological study in seven specialities. J Psychosom Res. 2001;51(1):361-7. PubMed pmid: 11448704.CrossRefPubMed
4.
Kato K, Sullivan PF, Evengard B, Pedersen NL. A population-based twin study of functional somatic syndromes. Psychol Med. 2009;39(3):497-505. doi: 10.1017/s0033291708003784. PubMed pmid: 18578896; PubMed Central pmcid: PMCPMC3947533.CrossRefPubMedPubMedCentral
5.
Kanaan RA, Armstrong D, Wessely SC. Neurologists’ understanding and management of conversion disorder. J Neurol Neurosurg Psychiatry. 2011;82(9):961-6. doi: 10.1136/jnnp.2010.233114. PubMed pmid: 21325661; PubMed Central pmcid: PMCPMC3191819.CrossRef
6.
Vermeulen M, Willems MH.Conversion disorder: from dsm IV to dsm 5 or from a psychiatric to a neurological diagnosis. Tijdschr Psychiatr. 2015;57(8):569-76. PubMed pmid: 26402892.
7.
Lucassen PL, Olde Hartman TC, Borghuis M. Somatische fixatie. Een nieuw leven voor een oud begrip. Huisarts en Wetenschap. 2009;50(1):11-5.CrossRef
8.
Hellhammer DH, Wust S, Kudielka BM. Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology. 2009;34(2):163-71. doi: 10.1016/j.psyneuen.2008.10.026. PubMed pmid: 19095358.CrossRefPubMed
9.
Kleinstauber M, Witthoft M, Steffanowski A, van Marwijk H, Hiller W, Lambert MJ. Pharmacological interventions for somatoform disorders in adults. Cochrane Database Syst Rev. 2014;(11):CD010628. doi: 10.1002/14651858.CD010628.pub2. PubMed pmid: 25379990.
10.
van der Feltz-Cornelis CM, Nuyen J, Stoop C, Chan J, Jacobson AM, Katon W, et al. Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis. Gen Hosp Psychiatry. 2010;32(4):380-95.doi: 10.1016/j.genhosppsych.2010.03.011. PubMed pmid: 20633742.CrossRefPubMed
11.
Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with coronary artery disease. Cochrane Database Syst Rev. 2011;(9):CD008012. doi: 10.1002/4651858.CD008012.pub3. PubMed pmid: 21901717.
12.
van Dessel N, den Boeft M, van der Wouden JC, Kleinstauber M, Leone SS, Terluin B, et al. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database Syst Rev. 2014;(11):CD011142. doi: 10.1002/14651858.CD011142.pub2. PubMed pmid: 25362239.
13.
van der Feltz-Cornelis CM, Van Os TW, Van Marwijk HW, Leentjens AF. Effect of psychiatric consultation models in primary care. A systematic review and metaanalysis of randomized clinical trials. J Psychosom Res. 2010;68(6):521-33. doi: 10.1016/j.jpsychores.2009.10.012. PubMed pmid: 20488268.CrossRefPubMed
14.
van der Feltz-Cornelis CM, Andrea H, Kessels E, Duivenvoorden HJ, Biemans H, Metz M.Does routine outcome monitoring have a promising future? An investigation into the use of shared decision-making combined with ROM for patients with a combination of physical and psychiatric symptoms. Tijdschr Psychiatr. 2014;56(6):375-84. PubMed pmid: 24953511.
15.
De Heer E, De Wilde-Timmerman L, Dekker J, Beekman atf, Van Marwijk HWJ, Holwerda TJ, Bet PM, Van der Feltz-CornelisCM. Efficacy of Collaborative Care versus antidepressant treatment in chronic pain and major depression: a multi center proof of concept study, Journal of Psychosomatic Research 2016 June doi: 10.1016/j.jpsychores.2016.03.149.
16.
Roberts RG, Gask L, Arndt B, Bower P, Dunbar J, van der Feltz-Cornelis CM, et al. Depression and diabetes: the role and impact of models of health care systems. J Affect Disord. 2012;142 Suppl:S80-8. doi: 10.1016/S0165-0327(12)70012-5. PubMed pmid: 23062862.CrossRefPubMed
1.
Joffe RT, Young LT, MacQueen GM. A two-illness model of bipolar disorder. Bipolar Disord. 1999;1(1):25-30. PubMed pmid: 11256651.
2.
Kraepelin E. Psychiatrie. Ein Lehrbuch für Studirende und Aerzte. II. Band. Sechste Auflage. Leipzig: Verlag Barth; 1899.
3.
Kuyck WGE, Vonk R. Cycloide Psychose: een vergeten diagnose? Tijdschrift voor Psychatrie. 2003;45(2):97-108.
4.
Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007;64(5):543-52. doi: 10.1001/archpsyc.64.5.543. PubMed pmid: 17485606; PubMed Central pmcid: PMCPMC1931566.CrossRefPubMedPubMedCentral
5.
Goodwin FK, Jamison KR. Manic-depressive illness (2e edition). New York: Oxford University Press; 2007.
6.
de graaf R, ten Have M, van Dorsselaer S. De psychische gezondheid van de Nederlandse bevolking. nemesis-2: opzet en eerste resultaten. Utrecht: Trimbos Instituut; 2010.
7.
Barnett JH, Smoller JW. The genetics of bipolar disorder. Neuroscience. 2009;164(1):331-43. doi: 10.1016/j.neuroscience.2009.03.080. PubMed pmid: 19358880; PubMed Central pmcid: pmcpmc3637882.CrossRefPubMed
8.
Knowles R, Tai S, Jones SH, Highfield J, Morriss R, Bentall RP. Stability of self-esteem in bipolar disorder: comparisons among remitted bipolar patients, remitted unipolar patients and healthy controls. Bipolar Disord. 2007;9(5):490-5. doi: 10.1111/j.1399-5618.2007.00457.x. PubMed pmid: 17680919.CrossRefPubMed
9.
Lam D, Wright K, Smith N. Dysfunctional assumptions in bipolar disorder. J Affect Disord. 2004;79(1-3):193-9. doi: 10.1016/S0165-0327(02)00462-7. PubMed pmid: 15023494.CrossRefPubMed
10.
Urosevic S, Abramson LY, Harmon-Jones E, Alloy LB. Dysregulation of the behavioral approach system (BAS) in bipolar spectrum disorders: review of theory and evidence. Clin Psychol Rev. 2008;28(7):1188-205. doi: 10.1016/j.cpr.2008.04.004. PubMed pmid: 18565633; PubMed Central pmcid: pmcpmc2606106.CrossRefPubMedPubMedCentral
11.
Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry. 1992;149(8):999-1010. doi: 10.1176/ajp.149.8.999. PubMed pmid: 1353322.
12.
Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370(9584):319-28. doi: 10.1016/S0140-6736(07)61162-3. PubMed pmid: 17662880.CrossRef
13.
Grandin LD, Alloy LB, Abramson LY. The social zeitgeber theory, circadian rhythms, and mood disorders: review and evaluation. Clin Psychol Rev. 2006;26(6):679-94. doi: 10.1016/j.cpr.2006.07.001. PubMed pmid: 16904251.CrossRefPubMed
14.
Kupka RW, Goossens P, van Bendegem M, Daemen P, Daggenvoorde T, Daniels M, et al. Multidisciplinaire Richtlijn Bipolaire Stoornissen. Utrecht: De Tijdstroom; 2015.
15.
Colom F, Vieta E, Sanchez-Moreno J, Palomino-Otiniano R, Reinares M, Goikolea JM, et al. Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial. Br J Psychiatry. 2009;194(3):260-5. doi: 10.1192/bjp.bp.107.040485. PubMed pmid: 19252157.CrossRef
16.
Basco M, Rush A. Cognitive-behavioral treatment of manic-depressive disorder (2e edition). New York: Guildford Press; 2005.
17.
Frank E. Treating bipolar disorder: A clinician’s guide to interpersonal and social rhythm therapy. New York: Guildford Press; 2005.
18.
Miklowitz DJ. Bipolar disorder: A family-focused treatment (2e edition). New York: Guildford Press; 2008.
1.
van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med. 2009;39(2):179-95. doi: 10.1017/s0033291708003814. PubMed pmid: 18606047.CrossRefPubMed
2.
McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 2008;30:67-76. doi: 10.1093/epirev/mxn001. PubMed pmid: 18480098.CrossRefPubMed
3.
Veling W, Van der Wal M, Jansen S, van Weeghel J, Linszen DH. Handboek vroege psychose. Utrecht: swp; 2012.
4.
Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rossler A, Schultze-Lutter F, et al. The psychosis high-risk state: a comprehensive state-of-the-art review. jama Psychiatry. 2013;70(1):107-20. doi: 10.1001/jamapsychiatry.2013.269. PubMed pmid: 23165428; PubMed Central pmcid: PMCPMC4356506.CrossRefPubMedPubMedCentral
5.
Bertelsen M, Jeppesen P, Petersen L, Thorup A, Ohlenschlaeger J, Le Quach P, et al. Course of illness in a sample of 265 patients with first-episode psychosis--five-year follow-up of the Danish OPUS trial. Schizophr Res. 2009;107(2-3):173-8. doi: 10.1016/j.schres.2008.09.018. PubMed pmid: 18945593.CrossRefPubMed
6.
Lambert M, Naber D, Schacht A, Wagner T, Hundemer HP, Karow A, et al. Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia. Acta Psychiatr Scand. 2008;118(3):220-9. doi: 10.1111/j.1600-0447.2008.01213.x. PubMed pmid: 18699954.CrossRefPubMed
7.
Selten JP, Veen ND, Hoek HW, Laan W, Schols D, van der Tweel I, et al. Early course of schizophrenia in a representative Dutch incidence cohort. Schizophr Res. 2007;97(1-3):79-87. doi: 10.1016/j.schres.2007.07.008. PubMed pmid: 17683911.CrossRefPubMed
8.
Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF, et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a populationbased study. Lancet. 2009;373(9659):234-9. doi: 10.1016/S0140-6736(09)60072-6. PubMed pmid: 19150704; PubMed Central pmcid: pmcpmc3879718.CrossRef
9.
Schizophrenia Working Group of the Psychiatric Genomics C. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511(7510):421-7. doi: 10.1038/nature13595. PubMed pmid: 25056061; PubMed Central pmcid: PMCPMC4112379.
10.
Garety PA, Kuipers E, Fowler D, Freeman D, Bebbington PE. A cognitive model of the positive symptoms of psychosis. Psychol Med. 2001;31(2):189-95. PubMed pmid: 11232907.
11.
Varese F, Smeets F, Drukker M, Lieverse R, Lataster T, Viechtbauer W, et al. Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective and cross-sectional cohort studies. Schizophr Bull. 2012;38(4):661-71. doi: 10.1093/schbul/sbs050. PubMed pmid: 22461484; PubMed Central pmcid: pmcpmc3406538.CrossRefPubMedPubMedCentral
12.
Bourque F, van der Ven E, Malla A. A meta-analysis of the risk for psychotic disorders among first- and second-generation immigrants. Psychol Med. 2011;41(5):897-910. doi: 10.1017/S0033291710001406. PubMed pmid: 20663257.CrossRefPubMed
13.
Veling W, Susser E, van Os J, Mackenbach JP, Selten JP, Hoek HW. Ethnic density of neighborhoods and incidence of psychotic disorders among immigrants. Am J Psychiatry. 2008;165(1):66-73. doi: 10.1176/appi.ajp.2007.07030423. PubMed pmid: 18086750.CrossRefPubMed
14.
Veling W, Selten JP, Veen N, Laan W, Blom JD, Hoek HW. Incidence of schizophrenia among ethnic minorities in the Netherlands: a four-year first-contact study. Schizophr Res. 2006;86(1-3):189-93. doi: 10.1016/j.schres.2006.06.010. PubMed pmid: 16839747.CrossRefPubMed
15.
Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370(9584):319-28. doi: 10.1016/S0140-6736(07)61162-3. PubMed pmid: 17662880.CrossRef
16.
Vassos E, Pedersen CB, Murray RM, Collier DA, Lewis CM. Meta-analysis of the association of urbanicity with schizophrenia. Schizophrenia Bulletin. 2012;38(6):1118-23.CrossRefPubMedPubMedCentral
17.
Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments metaanalysis. Lancet. 2013;382(9896):951-62. doi: 10.1016/S0140-6736(13)60733-3. PubMed PMID: 23810019.CrossRef
18.
Samara MT, Dold M, Gianatsi M, Nikolakopoulou A, Helfer B, Salanti G, et al. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis. jama Psychiatry. 2016;73(3):199-210. doi: 10.1001/jamapsychiatry.2015.2955. PubMed pmid: 26842482.CrossRefPubMed
19.
van den Berg DP, de Bont PA, van der Vleugel BM, de Roos C, de Jongh A, Van Minnen A, et al. Prolonged exposure vs eye movement desensitization and reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. jama Psychiatry. 2015;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PubMed pmid: 25607833.CrossRefPubMed
1.
American Psychiatric Association A. dsm-5: Diagnostic and Statistical Manual of Mental Disorders. Washinton DC.: APA.; 2013.
2.
Bernstein EM, Putnam FW. Development, reliability, and validity of a dissociation scale. J Nerv Ment Dis. 1986;174(12):727-35. PubMed pmid: 3783140.CrossRefPubMed
3.
Van der Hart O, Nijenhuis E, Steele K. Het belaagde zelf: Structurele dissociatie en de behandeling van chronische traumatisering. Amsterdam: Boom; 2010.
4.
Boon S. Multiple personality disorder in the Netherlands. Lisse: Swets & Zeitlinger; 1993.
5.
Boon S, Draijer, N. Screening en diagnostiek van dissociatieve stoornissen. Lisse: Swets & Zeitlinger; 1995.
6.
Waller NG, Putnam FW, Carlson EB. Types of dissociation and dissociative types: A taxonomic analysis of dissociative experiences. Psychological Methods. 1996;1:300-21.CrossRef
7.
Nijenhuis ER, Van der Hart O. Dissociation in trauma: a new definition and comparison with previous formulations. J Trauma Dissociation. 2011;12(4):416-45. doi: 10.1080/15299732.2011.570592. PubMed pmid: 21667387.CrossRef
8.
Sar V. Epidemiology of dissociative disorders: An overview. Epidemiology Research International. 2011;2011(Article ID 404538):8.CrossRef
9.
Foote B, Smolin Y, Kaplan M, Legatt ME, Lipschitz D. Prevalence of dissociative disorders in psychiatric outpatients. Am J Psychiatry. 2006;163(4):623-9. doi: 10.1176/appi.ajp.163.4.623. PubMed pmid: 16585436.CrossRefPubMed
10.
Friedl MC, Draijer N. Dissociative disorders in Dutch psychiatric inpatients. Am J Psychiatry. 2000;157(6):1012-3. doi: 10.1176/appi.ajp.157.6.1012. PubMed pmid: 10831486.CrossRefPubMed
11.
Schlumpf YR, Nijenhuis ER, Chalavi S, Weder EV, Zimmermann E, Luechinger R, et al. Dissociative part-dependent biopsychosocial reactions to backward masked angry and neutral faces: An fMRI study of dissociative identity disorder. Neuroimage Clin. 2013;3:54-64. doi: 10.1016/j.nicl.2013.07.002. PubMed pmid: 24179849; PubMed Central pmcid: pmcpmc3791283.CrossRef
12.
Schlumpf YR, Reinders AA, Nijenhuis ER, Luechinger R, Van Osch MJ, Jancke L. Dissociative part-dependent resting-state activity in dissociative identity disorder: a controlled fmri perfusion study. PLoS One. 2014;9(6):e98795. doi: 10.1371/journal.pone.0098795. PubMed pmid: 24922512; PubMed Central pmcid: PMCPMC4055615.CrossRefPubMedPubMedCentral
13.
Freyd JJ. Betrayal trauma: The logic of forgetting childhood trauma. Cambrige ma: Harvard University Press; 1996..
14.
Boon S. The treatment of traumatic memories in did: Indications and contra-indications. Dissociation. 1997;10:65-80.
15.
Steele K, Boon S, Van der Hart O. trauma-related dissociation: A practical integrative approach. New York: Norton; 2017.
16.
International Society for the Study of Trauma and Dissociation. Guidelines for treating dissociative identity disorder in adults, third revision. Journal of Trauma & Dissociation. 2011;12(2):115-87.CrossRef
17.
Van der Hart O. Trauma, dissociatie en hypnose (4e gewijzigde druk). Lisse: Swets & Zeitlinger; 2003.
18.
Draijer N, Langeland W, Boon S. Klinische diagnostiek van complexe traumagerelateerde stoornissen. In: Vermetten E, Kleber RJ, Van der Hart O, red.. Handboek posttraumatische stress-stoornissen. Utrecht: De Tijdstroom; 2012. p. 491-510.
19.
Boon S, Steele K, Van der Hart O. Omgaan met traumagerelateerde dissociatie: Vaardigheidstraining voor patiënten en hun therapeuten. Amsterdam: Pearson; 2012.
1.
Ohayon MM, Carskadon MA, Guilleminault C, Vitiello MV. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep. 2004;27(7):1255-73. PubMed pmid: 15586779.CrossRefPubMed
2.
van Bemmel, AL., & van Diest, R. (2011). Slaapstoornissen. In J. A. M. Vandermeulen, J. A. Den Boer, & M. Derix (rred.), Onderzoek naar bewustzijn. Amsterdam: Boom.
3.
Bes F, Schulz H, Navelet Y, Salzarulo P. The distribution of slow-wave sleep across the night: a comparison for infants, children, and adults. Sleep. 1991;14(1):5-12. PubMed pmid: 1811320.CrossRefPubMed
4.
5.
Jiang XL, Zheng XY, Yang J, Ye CP, Chen YY, Zhang ZG, et al. A systematic review of studies on the prevalence of insomnia in university students. Public Health. 2015;129(12):1579-84. doi: 10.1016/j.puhe.2015.07.030. PubMed pmid: 26298588.CrossRefPubMed
6.
7.
Abbott SM, Reid KJ, Zee PC. Circadian Rhythm Sleep-Wake Disorders. Psychiatr Clin North Am. 2015;38(4):805-23. doi: 10.10167j.psc.2015.07.012. PubMed pmid: 26600110.
8.
Bjorvatn B, Gronli J, Pallesen S. Prevalence of different parasomnias in the general population. Sleep Med. 20l0;ll(l0):l03l-4. doi: l0.l0l6/j.sleep.20l0.07.0ll. PubMed pmid: 21093361.
9.
Saper CB, Chou TC, Scammell TE. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci. 200l;24(l2):726-3l. PubMed pmid: 11718878.CrossRefPubMed
10.
Pacchierotti C, lapichino S, Bossini L, Pieraccini F, Castrogiovanni P. Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry. Front Neuroendocrinol. 200l;22(l):l8-32. doi: l0.l006/fme.2000.0202. PubMed pmid: 11141317.
11.
Morgenthaler T, Kramer M, Alessi C, Friedman L, Boehlecke B, Brown T, et al. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An american academy of sleep medicine report. Sleep. 2006;29(ll):l4l5-9. PubMed pmid: 17162987.
12.
Smith MT, Perlis ML, Park A, Smith MS, Pennington J, Giles DE, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry. 2002;l59(l):5-ll. doi: l0.ll76/appi.ajp.l59.l.5. PubMed pmid: 11772681.
1.
Multidisciplinaire Richtlijn Eetstoornissen. Utrecht: CBO: Trimbos instuut; 2006.
2.
Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Curr Opin Psychiatry. 2006;19(4):389-94. doi: 10.1097/01.yco.0000228759.95237.78. PubMed pmid: 16721169.CrossRefPubMed
3.
Forsberg S, Lock J. Family-based Treatment of Child and Adolescent Eating Disorders. Child Adolesc Psychiatr Clin N Am. 2015;24(3):617-29. doi: 10.1016/j.chc.2015.02.012. PubMed pmid: 26092743.CrossRefPubMed
1.
Kedde H. Seksuele disfuncties in Nederland: prevalentie en samenhangende factoren. Tijdschrift voor Seksuologie 2012;36(2):98-108.
2.
Herder T, de Boer MK, Knegtering H. Seksualiteit bij de mens met psychatrisch problemen. ggz Wetenschappelijk. 2016;1:50-68.
3.
Masters WH, Johnson VE. Human Sexual Response. Toronto / New York: Bantham Books; 1966.
4.
de Boer MK, Castelein S, Wiersma D, Schoevers RA, Knegtering H. The facts about sexual (Dys)function in schizophrenia: an overview of clinically relevant findings. Schizophr Bull. 2015;41(3):674-86. doi: 10.1093/schbul/sbv001. PubMed pmid: 25721311; PubMed Central pmcid: pmcpmc4393701.CrossRefPubMedPubMedCentral
5.
Hatzichristou D, Kirana PS, Banner L, Althof SE, Lonnee-Hoffmann RA, Dennerstein L, et al. Diagnosing Sexual Dysfunction in Men and Women: Sexual History Taking and the Role of Symptom Scales and Questionnaires. J Sex Med. 2016;13(8):1166-82. doi: 10.1016/j.jsxm.2016.05.017. PubMed pmid: 27436074.CrossRefPubMed
6.
Rizvi SJ, Yeung NW, Kennedy SH. Instruments to measure sexual dysfunction in community and psychiatric populations. J Psychosom Res. 2011;70(1):99-109. doi: 10.1016/j.jpsychores.2010.05.009. PubMed pmid: 21193105.CrossRefPubMed
7.
1.
Heyman GM. Quitting drugs: quantitative and qualitative features. Annu Rev Clin Psychol. 2013;9:29-59. doi: 10.1146/annurev-clinpsy-032511-143041. PubMed pmid:23330937.CrossRefPubMed
2.
Dom G, Brink W, van den. Middelengerelateerd stoornissen en verslavingsstoornissen. Neurobiologische behandelingen. Hengeveld MW, Balkom AJJMv, Van Heeringen C, Sabbe BGC, red. Utrecht: de Tijdstroom; 2016.
3.
Hoskins M, Pearce J, Bethell A, Dankova L, Barbui C, Tol WA, et al. Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis. Br J Psychiatry. 2015;206(2):93-100. doi: 10.1192/bjp.bp.114.148551. PubMed pmid: 25644881.CrossRef
4.
Volkow ND, Swanson JM, Evins AE, DeLisi LE, Meier MH, Gonzalez R, et al. Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review. jama Psychiatry. 2016;73(3):292-7. doi: 10.1001/jamapsychiatry.2015.3278. PubMed pmid: 26842658.CrossRefPubMed
5.
Grant BF, Saha TD, Ruan WJ, Goldstein RB, Chou SP, Jung J, et al. Epidemiology of dsm-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. jama Psychiatry. 2016;73(1):39-47. doi: 10.1001/jamapsychiatry.2015.2132. PubMed pmid: 26580136.CrossRefPubMedPubMedCentral
6.
Soyez V, De Wilde J, Vandervelde S, Vander Beken T, Todts S, Broekaert E. Screening en assessment van psychiatrische stoornissen in Belgisch gevangenissen.. Verslaving. 2010;1.
7.
Bulten BH, van Tilburg W, Limbeek. v. Psychopathologie bij gedetineerden. Tijdschift voor psychiatrie. 1999;41(10):575-85.
8.
Kwako LE, Momenan R, Litten RZ, Koob GF, Goldman D. Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders. Biol Psychiatry. 2016;80(3):179-89. doi: 10.1016/j.biopsych.2015.10.024. PubMed pmid: 26772405; PubMed Central pmcid: pmcpmc4870153.CrossRefPubMed
9.
Dom, G, Van den Brink, W. Motivatie, gedrag en verslaving. In Hengelveld et al. red. Leerboek Psychiatrie, 3de geheel herziene druk, hoofdstuk 3.3.13, 116-120. De Tijdstroom; 2016.
10.
Lewis MD. Dopamine and the Neural “Now”: Essay and Review of Addiction: A Disorder of Choice. Perspect Psychol Sci. 2011;6(2):150-5. doi: 10.1177/1745691611400235. PubMed pmid: 26162132.CrossRefPubMed
11.
Dom G, Samochowiec J, Evans-Lacko S, Wahlbeck K, Van Hal G, McDaid D. The Impact of the 2008 Economic Crisis on Substance Use Patterns in the Countries of the European Union. Int J Environ Res Public Health. 2016;13(1). doi: 10.3390/ijerph13010122. PubMed pmid: 26771628; PubMed Central pmcid: pmcpmc4730513.CrossRefPubMedCentral
12.
Martin-Carrasco M, Evans-Lacko S, Dom G, Christodoulou NG, Samochowiec J, Gonzalez-Fraile E, et al. EPA guidance on mental health and economic crises in Europe. Eur Arch Psychiatry Clin Neurosci. 2016;266(2):89-124. doi: 10.1007/s00406-016-0681-x. PubMed pmid: 26874960.CrossRefPubMed
13.
Moeller SJ, Bederson L, Alia-Klein N, Goldstein RZ. Neuroscience of inhibition for addiction medicine: from prediction of initiation to prediction of relapse. Prog Brain Res. 2016;223:165-88. doi: 10.1016/bs.pbr.2015.07.007. PubMed pmid: 26806776.CrossRef
14.
Goodkind M, Eickhoff SB, Oathes DJ, Jiang Y, Chang A, Jones-Hagata LB, et al. Identification of a common neurobiological substrate for mental illness. jama Psychiatry. 2015;72(4):305-15. doi: 10.1001/jamapsychiatry.2014.2206. PubMed pmid: 25651064; PubMed Central pmcid: pmcpmc4791058.CrossRefPubMedPubMedCentral
15.
Ansell EB, Gu P, Tuit K, Sinha R. Effects of cumulative stress and impulsivity on smoking status. Hum Psychopharmacol. 2012;27(2):200-8. doi: 10.1002/hup.1269. PubMed pmid: 22389084; PubMed Central pmcid: pmcpmc3582663.CrossRef
16.
van den Brink W. Evidence-based pharmacological treatment of substance use disorders and pathological gambling. Curr Drug Abuse Rev. 2012;5(1):3-31. PubMed pmid: 22126708.
17.
Prochaska JO, DiClemente CC. Stages of change in the modification of problem behaviors. Prog Behav Modif. 1992;28:183-218. PubMed pmid: 1620663.
18.
Zilverstand A, Parvaz MA, Moeller SJ, Goldstein RZ. Cognitive interventions for addiction medicine: Understanding the underlying neurobiological mechanisms. Prog Brain Res. 2016;224:285-304. doi: 10.1016/bs.pbr.2015.07.019. PubMed pmid: 26822363.CrossRef
19.
De Groot F, Morrens M, Dom G. [Acceptance and commitment therapy (act) and addiction: a literature review]. Tijdschr Psychiatr. 2014;56(9):577-85. PubMed pmid: 25222094.
20.
Walter KN, Petry NM. Motivation and Contingency Management Treatments for Substance Use Disorders. Curr Top Behav Neurosci. 2016;27:569-81. doi: 10.1007/7854_2015_374. PubMed pmid: 25762429.CrossRef
21.
Riper H, Blankers M, Hadiwijaya H, Cunningham J, Clarke S, Wiers R, et al. Effectiveness of guided and unguided low-intensity internet interventions for adult alcohol misuse: a meta-analysis. PLoS One. 2014;9(6):e99912. doi: 10.1371/journal.pone.0099912. PubMed pmid: 24937483; PubMed Central pmcid: pmcpmc4061051.CrossRefPubMedPubMedCentral
22.
Westman J, Wahlbeck K, Laursen TM, Gissler M, Nordentoft M, Hallgren J, et al. Mortality and life expectancy of people with alcohol use disorder in Denmark, Finland and Sweden. Acta Psychiatr Scand. 2015;131(4):297-306. doi: 10.1111/acps.12330. PubMed pmid: 25243359; PubMed Central pmcid: pmcpmc4402015.CrossRefPubMedPubMedCentral
23.
Toftdahl NG, Nordentoft M, Hjorthoj C. Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study. Soc Psychiatry Psychiatr Epidemiol. 2016;51(1):129-40. doi: 10.1007/s00127-015-1104-4. PubMed pmid: 26260950.CrossRefPubMed
24.
Dom G, Moggi F. Co-occurring Addictive and Psychiatric Disorders. Edition: 1st Edition. In: Dom G, Moggi F, editors. Subtitle: A Practice-Based Handbook from a European Perspective2015. p. 375-89.
1.
Heyman GM, Dunn B. Decision biases and persistent illicit drug use: an experimental study of distributed choice and addiction. Drug Alcohol Depend. 2002;67(2):193-203. PubMed pmid: 12095669.CrossRefPubMed
2.
Garriga M, Pacchiarotti I, Kasper S, Zeller SL, Allen MH, Vazquez G, et al. Assessment and management of agitation in psychiatry: Expert consensus. World J Biol Psychiatry. 2016;17(2):86-128. doi: 10.3109/15622975.2015.1132007. PubMed pmid: 26912127.CrossRefPubMed
3.
Grant BF, Saha TD, Ruan WJ, Goldstein RB, Chou SP, Jung J, et al. Epidemiology of dsm-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. jama Psychiatry. 2016;73(1):39-47. doi: 10.1001/jamapsychiatry.2015.2132. PubMed pmid: 26580136; PubMed Central pmcid: PMCPMC5062605.CrossRefPubMedPubMedCentral
4.
Volkow ND, Swanson JM, Evins AE, DeLisi LE, Meier MH, Gonzalez R, et al. Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review. jama Psychiatry. 2016;73(3):292-7. doi: 10.1001/jamapsychiatry.2015.3278. PubMed pmid: 26842658.CrossRefPubMed
5.
Kwako LE, Momenan R, Litten RZ, Koob GF, Goldman D. Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders. Biol Psychiatry. 2016;80(3):179-89. doi: 10.1016/j.biopsych.2015.10.024. PubMed pmid: 26772405; PubMed Central pmcid: pmcpmc4870153.CrossRefPubMed
6.
Bak M, van Os J, Marcelis M. [Rapid tranquillisation; review of the literature and recommendations]. Tijdschr Psychiatr. 2011;53(10):727-37. PubMed pmid: 21989751.
1.
Happe F, Booth R, Charlton R, Hughes C. Executive function deficits in autism spectrum disorders and attention-deficit/hyperactivity disorder: examining profiles across domains and ages. Brain Cogn. 2006;61(1):25-39. doi: 10.1016/j.bandc.2006.03.004. PubMed pmid: 16682102.CrossRefPubMed
2.
Kempes M, Matthys W, de Vries H, van Engeland H. Reactive and proactive aggression in children--a review of theory, findings and the relevance for child and adolescent psychiatry. Eur Child Adolesc Psychiatry. 2005;14(1):11-9. doi: 10.1007/s00787-005-0432-4. PubMed pmid: 15756511.CrossRef
3.
Brugha TS, McManus S, Bankart J, Scott F, Purdon S, Smith J, et al. Epidemiology of autism spectrum disorders in adults in the community in England. Arch Gen Psychiatry. 2011;68(5):459-65. doi: 10.1001/archgenpsychiatry.2011.38. PubMed pmid: 21536975.CrossRefPubMed
4.
nvvp. Richtlijn ADHD bij volwassenen - Fase I: Diagnostiek en medicamenteuze behandeling:. In: Psychiatrie NVv, editor. 2015.
5.
Mattheys W, van de Glind G. Richtlijn oppositioneel-opstandige stoornis (ODD) en gedragsstoornis (CD) bij kinderen en jongeren. Utrecht: de Tijdstroom; 2013.
6.
Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003;160(1):13-23. doi: 10.1176/appi.ajp.160.1.13. PubMed pmid: 12505794.CrossRefPubMed
7.
Fusar-Poli P, Rubia K, Rossi G, Sartori G, Balottin U. Striatal dopamine transporter alterations in ADHD: pathophysiology or adaptation to psychostimulants? A metaanalysis. Am J Psychiatry. 2012;169(3):264-72. doi: 10.1176/appi.ajp.2011.11060940. PubMed pmid: 22294258.CrossRefPubMed
8.
de Zeeuw P, Schnack HG, van Belle J, Weusten J, van Dijk S, Langen M, et al. Differential brain development with low and high lQ in attention-deficit/hyperactivity disorder. PLoS One. 2012;7(4):e35770. doi: 10.1371/journal.pone.0035770. PubMed pmid: 22536435; PubMed Central pmcid: pmcpmc3335015.CrossRefPubMedPubMedCentral
9.
Rutter ML. Progress in understanding autism: 2007-2010. J Autism Dev Disord. 2011;41(4):395-404. doi: 10.1007/s10803-011-1184-2. PubMed pmid: 21318644.CrossRefPubMed
10.
Snoek H, van Goozen SH, Matthys W, Sigling HO, Koppeschaar HP, Westenberg HG, et al. Serotonergic functioning in children with oppositional defiant disorder: a sumatriptan challenge study. Biol Psychiatry. 2002;51(4):319-25. PubMed pmid: 11958783.CrossRefPubMed
11.
Matthys W, Van Loo P, Pachen V, De Vries H, Van Hooff JA, Van Engeland H. Behavior of conduct disordered children in interaction with each other and with normal peers. Child Psychiatry Hum Dev. 1995;25(3):183-95. PubMed pmid: 7736803.CrossRefPubMed
12.
Noreika V, Falter CM, Rubia K. Timing deficits in attention-deficit/hyperactivity disorder (ADHD): evidence from neurocognitive and neuroimaging studies. Neuropsychologia. 2013;51(2):235-66. doi: 10.1016/j.neuropsychologia.2012.09.036. PubMed pmid: 23022430.CrossRefPubMed
13.
Seidman LJ, Valera EM, Makris N. Structural brain imaging of attention-deficit/ hyperactivity disorder. Biol Psychiatry. 2005;57(11):1263-72. doi: 10.1016/j.biopsych.2004.11.019. PubMed pmid: 15949998.CrossRefPubMed
14.
Happe FG. Annotation: current psychological theories of autism: the “theory of mind” account and rival theories. J Child Psychol Psychiatry. 1994;35(2):215-29. PubMed pmid: 8188796.CrossRefPubMed
15.
Happe F, Frith U. The weak coherence account: detail-focused cognitive style in autism spectrum disorders. J Autism Dev Disord. 2006;36(1):5-25. doi: 10.1007/s10803-005-0039-0. PubMed pmid: 16450045.CrossRefPubMed
16.
Matthys W, Cuperus JM, Van Engeland H. Deficient social problem-solving in boys with ODD/CD, with ADHD, and with both disorders. J Am Acad Child Adolesc Psychiatry. 1999;38(3):311-21. PubMed pmid: 10087693.CrossRef
17.
Orobio de Castro B, Veerman JW, Koops W, Bosch JD, Monshouwer HJ. Hostile attribution of intent and aggressive behavior: a meta-analysis. Child Dev. 2002;73(3):916-34. PubMed pmid: 12038560.CrossRef
18.
Matthys W, De Vries H, Hectors A, Veerbeek M, Heidemann W, Goud M, et al. Differences between conduct disordered and normal control children in their tendencies to escalate or neutralize conflicts when interacting with normal peers. Child Psychiatry Hum Dev. 1995;26(1):29-41. PubMed pmid: 7587478.CrossRefPubMed
19.
Volkow ND, Wang GJ, Fowler JS, Telang F, Maynard L, Logan J, et al. Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am J Psychiatry. 2004;161(7):1173-80. doi: 10.1176/appi.ajp.161.7.1173. PubMed pmid: 15229048.CrossRefPubMed
20.
Buitelaar JK. [Follow-up of the MTA-study in children with adhd: what do the data tell us, and what not?]. Tijdschr Psychiatr. 2010;52(4):255-7. PubMed pmid: 20503166.
21.
Kan CC, Geurts H, van de Bosch K, Forcevill E, van Manen J, Schuurman C, et al. Multidisciplinaire richtlijn diagnostiek en behandeling van autismespectrumstoornissen bij volwassenen. Utrecht: De Tijdstroom; 2013.
22.
Slade M, Bird V, Le Boutillier C, Williams J, McCrone P, Leamy M. REFOCUS Trial: protocol for a cluster randomised controlled trial of a pro-recovery intervention within community based mental health teams. bmc Psychiatry. 2011;11:185. doi: 10.1186/1471-244X-11-185. PubMed pmid: 22112008; PubMed Central pmcid: pmcpmc3235965.
1.
McWilliams N. Psychoanalytic diagnosis. New York: Guildford Press; 1994.
2.
Roberts BW, DelVecchio WF. The rank-order consistency of personality traits from childhood to old age: a quantitative review of longitudinal studies. Psychol Bull. 2000;126(1):3-25. PubMed pmid: 10668348.CrossRefPubMed
3.
Newton-Howes G, Clark LA, Chanen A. Personality disorder across the life course. Lancet. 2015;385(9969):727-34. doi: 10.1016/S0140-6736(14)61283-6. PubMed pmid: 25706218.CrossRef
4.
American Psychiatric Association A. dsm-5: Diagnostic and Statistical Manual of Mental Disorders. Washinton DC.: APA.; 2013.
5.
Moran P, Jenkins R, Tylee A, Blizard R, Mann A. The prevalence of personality disorder among UK primary care attenders. Acta Psychiatr Scand. 2000;102(1):52-7. PubMed pmid: 10892610.CrossRefPubMed
6.
Kool S, Dekker J, Schoevers RA. Depressie en persoonlijkheidspathologie. In: Eurelings-Bontekoe EHM, Verheul R, Snellen WM, editors. Handboek Persoonlijkhiedspathologie. Houten: Bohn Stafleu van Loghum; 2009.
7.
Visser S, van Balkom AJ. Angststoornissen en persoonlijkheidspathologie. In: Eurelings-Bontekoe EHM, Verheul R, Snellen WM, editors. Handboek Persoonlijkheidspathologie. Houten: Bohn Stafleu va Loghum; 2009.CrossRef
8.
Bateman AW, Krawitz R. Borderline personality disorder. An evidence based guide for generalist mental health profesionals. Oxford: Oxford Press; 2013.
9.
Quirk SE, Stuart AL, Brennan-Olsen SL, Pasco JA, Berk M, Chanen AM, et al. Physical health comorbidities in women with personality disorder: Data from the Geelong Osteoporosis Study. Eur Psychiatry. 2016;34:29-35. doi: 10.1016/j.eurpsy.2015.12.007. PubMed pmid: 26928343.CrossRefPubMed
10.
Stoffers JM, Vollm BA, Rucker G, Timmer A, Huband N, Lieb K. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2012;(8):CD005652. doi: 10.1002/14651858.CD005652.pub2. PubMed pmid: 22895952.
11.
Gunderson JG, Links P. Handbook of good psychiatric management for borderline personality disorder. arlington: American Psychiatric Publishing; 2014.
Metagegevens
Titel
8 Syndromen
Auteurs
Albert Leentjens
Frans Verhey
Copyright
2018
Uitgeverij
Bohn Stafleu van Loghum
Boek
Innovatief leerboek persoonlijke psychiatrie

Print ISBN: 978-90-368-2051-6

Elektronisch ISBN: 978-90-368-2052-3

Copyright: 2018

DOI
https://doi.org/10.1007/978-90-368-2052-3_30